Top compounds associated with response to PFDN4


Feature Type Standardized
Nominal ANOVA
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.065 0.05
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.061 0.05
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.087 0.05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.064 0.05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.05
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.069 0.05
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.073 0.05
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.058 0.05
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.068 0.05
Download CSV